12.2M XNYS Volume
XNYS 20 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 12,295 | 223,379 (0%) | 0% | 63.1 | 775,937 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 16,934 | 235,674 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 45,916 | 252,608 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,782 | 206,692 (0%) | 0% | 63.1 | 175,572 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,347 | 209,474 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,904 | 210,821 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,680 | 202,917 (0%) | 0% | 63.1 | 169,135 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,335 | 205,597 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,733 | 13,466 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,985 | 111,611 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 482 | 111,129 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 3,327 | 107,802 (0%) | 0% | 63.1 | 209,967 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,616 | 114,418 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,154 | 113,264 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,794 | 110,470 (0%) | 0% | 63.1 | 176,329 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,733 | 117,203 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,147 | 116,056 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,858 | 113,198 (0%) | 0% | 63.1 | 180,368 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 39,700 | 152,898 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 14,641 | 138,257 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 12,818 | 125,439 (0%) | 0% | 63.1 | 808,944 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,985 | 0 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,616 | 6,618 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 97,071 | 97,071 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 39,700 | 0 | - | - | Performance Shares | |
| Christopher S. Boerner | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 145,607 | 145,607 | - | - | Performance Shares | |
| Benjamin J. Hickey | President, RayzeBio Org. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 20,084 | 20,084 | - | - | Performance Shares | |
| Benjamin J. Hickey | President, RayzeBio Org. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 13,389 | 13,389 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,107 | 13,025 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 193 | 12,832 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 406 | 12,426 (0%) | 0% | 63.1 | 25,623 | Common Stock, $0.10 par value |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,342 | 14,768 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 399 | 14,369 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 862 | 13,507 (0%) | 0% | 63.1 | 54,401 | Common Stock, $0.10 par value |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,641 | 20,148 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 2,449 | 17,699 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,860 | 15,839 (0%) | 0% | 63.1 | 117,385 | Common Stock, $0.10 par value |
| Robert M. Plenge | EVP, Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 23,431 | 23,431 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 6,641 | 0 | - | - | Performance Shares | |
| Robert M. Plenge | EVP, Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 35,146 | 35,146 | - | - | Performance Shares | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,165 | 0 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,342 | 4,684 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,107 | 1,107 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,165 | 12,480 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 80 | 12,400 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 482 | 11,918 (0%) | 0% | 63.1 | 30,419 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,886 | 68,818 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 831 | 70,088 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,013 | 68,075 (0%) | 0% | 63.1 | 127,040 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,854 | 73,929 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 998 | 72,931 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,484 | 70,447 (0%) | 0% | 63.1 | 156,765 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 28,593 | 99,040 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 10,545 | 88,495 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 9,232 | 79,263 (0%) | 0% | 63.1 | 582,632 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,886 | 0 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,765 | 4,767 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,854 | 11,711 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 35,146 | 35,146 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 28,593 | 0 | - | - | Performance Shares | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 52,720 | 52,720 | - | - | Performance Shares | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 337 | 68,481 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,327 | 66,154 (0%) | 0% | 63.1 | 146,857 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,765 | 70,919 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 4,558 | 16,102 (0%) | 0% | 63.1 | 287,655 | Common Stock, $0.10 par value |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,836 | 9,832 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 495 | 9,337 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 994 | 8,343 (0%) | 0% | 63.1 | 62,731 | Common Stock, $0.10 par value |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,293 | 11,636 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 561 | 11,075 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,159 | 9,916 (0%) | 0% | 63.1 | 73,144 | Common Stock, $0.10 par value |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 17,021 | 26,937 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 6,277 | 20,660 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,836 | 2,839 | - | - | Market Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,293 | 6,587 | - | - | Market Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 25,439 | 25,439 | - | - | Market Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 17,021 | 0 | - | - | Performance Shares | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 38,159 | 38,159 | - | - | Performance Shares | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,447 | 7,783 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 427 | 7,356 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,034 | 6,322 (0%) | 0% | 63.1 | 65,256 | Common Stock, $0.10 par value |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,293 | 9,615 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 561 | 9,054 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,398 | 7,656 (0%) | 0% | 63.1 | 88,228 | Common Stock, $0.10 par value |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 14,683 | 22,339 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 5,415 | 16,924 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 4,741 | 12,183 (0%) | 0% | 63.1 | 299,205 | Common Stock, $0.10 par value |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,447 | 2,448 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 3,293 | 6,587 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 20,084 | 20,084 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 30,126 | 30,126 | - | - | Performance Shares | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 14,683 | 0 | - | - | Performance Shares | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 4,040 | 15,977 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 10,955 | 0 | - | - | Performance Shares | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 3,538 | 12,439 (0%) | 0% | 63.1 | 223,283 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 31,464 | 31,464 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,000 | 4,001 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,825 | 1,828 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,904 | 0 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,904 | 8,554 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 131 | 8,423 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 907 | 7,516 (0%) | 0% | 63.1 | 57,241 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,825 | 9,341 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 318 | 9,023 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 771 | 8,252 (0%) | 0% | 63.1 | 48,658 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 2,000 | 10,252 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 341 | 9,911 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 849 | 9,062 (0%) | 0% | 63.1 | 53,580 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 10,955 | 20,017 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 47,197 | 47,197 | - | - | Performance Shares | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 867 | 6,572 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 272 | 5,705 (0%) | 0% | 63.1 | 17,166 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 159 | 5,977 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 910 | 6,136 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 118 | 5,226 (0%) | 0% | 63.1 | 7,447 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 24 | 5,344 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 349 | 5,368 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 20,084 | 20,084 | - | - | Performance Shares | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,462 | 0 | - | - | Performance Shares | |
| Cari Gallman | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 13,389 | 13,389 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 867 | 1,734 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 910 | 912 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 349 | 0 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,290 | 8,322 (0%) | 0% | 63.1 | 81,412 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 2,014 | 9,612 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,462 | 11,626 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 260 | 6,164 (0%) | 0% | 63.1 | 16,409 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 148 | 6,424 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,050 | 2,102 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,015 | 0 | - | - | Performance Shares | |
| Lynelle Hoch | President, Cell Therapy Org. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 7,531 | 7,531 | - | - | Performance Shares | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 835 | 838 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 546 | 0 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,359 | 4,711 (0%) | 0% | 63.1 | 85,766 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,850 | 6,070 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,015 | 7,920 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 374 | 2,905 (0%) | 0% | 63.1 | 23,603 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 179 | 3,279 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 1,050 | 3,458 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 296 | 2,408 (0%) | 0% | 63.1 | 18,681 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 146 | 2,704 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 835 | 2,850 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 219 | 2,015 (0%) | 0% | 63.1 | 13,821 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 38 | 2,234 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 546 | 2,272 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 5,021 | 5,021 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 690 | 0 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 690 | 3,114 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 48 | 3,066 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 233 | 2,833 (0%) | 0% | 63.1 | 14,705 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 810 | 3,643 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 141 | 3,502 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 242 | 3,260 (0%) | 0% | 63.1 | 15,273 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 803 | 4,063 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 137 | 3,926 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 241 | 3,685 (0%) | 0% | 63.1 | 15,210 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,861 | 8,546 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,793 | 6,753 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,557 | 5,196 (0%) | 0% | 63.1 | 98,262 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 810 | 811 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 803 | 1,608 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 15,732 | 15,732 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,861 | 0 | - | - | Performance Shares | |
| Amanda Ahn Poole | EVP, Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 23,598 | 23,598 | - | - | Performance Shares | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 237 | 12,176 (0%) | 0% | 63.1 | 14,957 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 810 | 12,986 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,912 | 4,912 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 768 | 1,539 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 810 | 811 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 701 | 0 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 1,110 | 14,967 (0%) | 0% | 63.1 | 70,052 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 1,793 | 16,077 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,861 | 17,870 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 231 | 13,009 (0%) | 0% | 63.1 | 14,578 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 131 | 13,240 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 768 | 13,371 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 242 | 12,603 (0%) | 0% | 63.1 | 15,273 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 141 | 12,845 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 4,861 | 0 | - | - | Performance Shares | |
| Phil Holzer | SVP and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 7,368 | 7,368 | - | - | Performance Shares | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 701 | 12,461 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 48 | 12,413 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,259 | 352,206 (0%) | 0% | 63.1 | 142,565 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 404 | 352,839 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,790 | 350,049 (0%) | 0% | 63.1 | 176,077 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,349 | 355,398 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,858 | 353,243 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 933 | 354,465 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 37,155 | 37,155 | - | - | Performance Shares | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 32,096 | 0 | - | - | Performance Shares | |
| Sandra Leung | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 24,770 | 24,770 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,415 | 10,833 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,349 | 5,351 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,858 | 0 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 10,363 | 364,296 (0%) | 0% | 63.1 | 654,009 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 11,837 | 374,659 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 32,096 | 386,496 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 2,298 | 354,400 (0%) | 0% | 63.1 | 145,027 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 923 | 356,698 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 5,415 | 357,621 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,652 | 206,932 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.11 per share. | 10 Mar 2025 | 3,178 | 199,280 (0%) | 0% | 63.1 | 200,564 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2025 | 555 | 202,458 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 8,045 | 203,013 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 54,226 | 54,226 | - | - | Performance Shares | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 45,916 | 0 | - | - | Performance Shares | |
| David V. Elkins | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 36,151 | 36,151 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,904 | 15,808 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 7,652 | 7,654 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 8,045 | 0 | - | - | Market Share Units | |
| Benjamin J. Hickey | President, RayzeBio Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.62 per share. | 01 Mar 2025 | 1,630 | 8,789 (0%) | 0% | 59.6 | 97,181 | Common Stock, $0.10 par value |
| Benjamin J. Hickey | President, RayzeBio Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,286 | 6,572 | - | - | Restricted Stock Units | |
| Benjamin J. Hickey | President, RayzeBio Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2025 | 3,286 | 10,419 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 55.05 per share. | 20 Feb 2025 | 2,000 | 104,626 (0%) | 0% | 55.0 | 110,096 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Purchase of securities on an exchange or from another person at price $ 54.85 per share. | 14 Feb 2025 | 1,823 | 63,932 (0%) | 0% | 54.9 | 100,000 | Common Stock, $0.10 par value |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 30,681 | - | - | Deferred Share Units | |
| Michael R. McMullen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 7,826 | - | - | Deferred Share Units | |
| Phyllis R. Yale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 34,677 | - | - | Deferred Share Units | |
| Paula A. Price | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 20,434 | - | - | Deferred Share Units | |
| Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 60,937 | - | - | Deferred Share Units | |
| Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 32,223 | - | - | Deferred Share Units | |
| Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 56,856 | - | - | Deferred Share Units | |
| Karen H. Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 35,232 | - | - | Deferred Share Units | |
| Medina Manuel Hidalgo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 17,835 | - | - | Deferred Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 2,543 | 7,829 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 2,543 | 2,543 | - | - | Restricted Stock Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.95 per share. | 01 Feb 2025 | 833 | 6,996 (0%) | 0% | 58.9 | 49,105 | Common Stock, $0.10 par value |
| Deepak L. Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 14,488 | - | - | Deferred Share Units | |
| Benjamin J. Hickey | President, RayzeBio Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 10,078 | 20,158 | - | - | Restricted Stock Units | |
| Benjamin J. Hickey | President, RayzeBio Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.95 per share. | 01 Feb 2025 | 3,725 | 7,133 (0%) | 0% | 59.0 | 219,589 | Common Stock, $0.10 par value |
| Benjamin J. Hickey | President, RayzeBio Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 10,078 | 10,858 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Arduini Peter J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 596 | 56,788 | - | - | Deferred Share Units | |
| Theodore Samuels R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 884 | 52,748 | - | - | Deferred Share Units | |
| R. Yale Phyllis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 618 | 30,796 | - | - | Deferred Share Units | |
| McMullen R. Michael | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 552 | 4,220 | - | - | Deferred Share Units | |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 663 | 26,841 | - | - | Deferred Share Units | |
| Phil Holzer | SVP and Controller | Sale of securities on an exchange or to another person at price $ 55.62 per share. | 04 Nov 2024 | 700 | 11,760 (0%) | 0% | 55.6 | 38,931 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 2,964 | 104,169 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Nov 2024 | 55 | 104,114 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.32 per share. | 01 Nov 2024 | 1,488 | 102,626 (0%) | 0% | 54.3 | 80,828 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2024 | 2,964 | 8,894 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Purchase of securities on an exchange or from another person at price $ 54.67 per share. | 01 Nov 2024 | 1,830 | 62,109 (0%) | 0% | 54.7 | 100,055 | Common Stock, $0.10 par value |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 18,843 | 18,843 | - | - | Restricted Stock Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 18,843 | 18,843 | - | - | Restricted Stock Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 4,558 | 6,667 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Oct 2024 | 4,558 | 9,117 | - | - | Restricted Stock Units | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.76 per share. | 02 Oct 2024 | 1,648 | 5,019 (0%) | 0% | 53.8 | 88,596 | Common Stock, $0.10 par value |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 724 | 25,892 | - | - | Deferred Share Units | |
| Michael R. McMullen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 603 | 3,628 | - | - | Deferred Share Units | |
| Phyllis R. Yale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 676 | 29,847 | - | - | Deferred Share Units | |
| Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 652 | 55,577 | - | - | Deferred Share Units | |
| Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 966 | 51,297 | - | - | Deferred Share Units | |
| Deepak L. Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 169 | 10,696 | - | - | Deferred Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 1,061 | 2,122 | - | - | Restricted Stock Units | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.17 per share. | 01 Aug 2024 | 384 | 2,109 (0%) | 0% | 48.2 | 18,497 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 1,061 | 2,493 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Michael R. McMullen | Director | Other type of transaction at price $ 0.00 per share. | 29 Jul 2024 | 5 | 0 | - | - | Call Option (obligation to sell) | |
| Michael R. McMullen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 2,986 | 2,986 | - | - | Deferred Share Units | |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 902 | 24,857 | - | - | Deferred Share Units | |
| Phyllis R. Yale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 842 | 28,812 | - | - | Deferred Share Units | |
| Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 825 | 54,249 | - | - | Deferred Share Units | |
| Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 1,203 | 49,712 | - | - | Deferred Share Units | |
| Deepak L. Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 210 | 10,397 | - | - | Deferred Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 01 May 2024 | 1,373 | 4,121 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,306 | 6,532 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.99 per share. | 01 Apr 2024 | 1,196 | 5,336 (0%) | 0% | 53.0 | 63,376 | Common Stock, $0.10 par value |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,306 | 6,613 | - | - | Restricted Stock Units | |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 691 | 23,634 | - | - | Deferred Share Units | |
| Gerald L. Storch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 691 | 88,158 | - | - | Deferred Share Units | |
| Phyllis R. Yale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 645 | 27,595 | - | - | Deferred Share Units | |
| Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 645 | 52,708 | - | - | Deferred Share Units | |
| Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 922 | 47,858 | - | - | Deferred Share Units | |
| Deepak L. Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 161 | 10,050 | - | - | Deferred Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 5,789 | 337,203 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 42,957 | 42,957 | - | - | Performance Shares | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 35,139 | 0 | - | - | Performance Shares | |
| Sandra Leung | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 28,638 | 28,638 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 5,415 | 16,248 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 5,349 | 10,700 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 5,856 | 5,858 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 5,789 | 0 | - | - | Market Share Units | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 35,139 | 371,312 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,475 | 336,173 (0%) | 0% | 53.8 | 133,130 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 12,232 | 359,080 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 11,695 | 347,385 (0%) | 0% | 53.8 | 629,074 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,009 | 338,648 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 5,856 | 339,657 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Sandra Leung | EVP, General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,490 | 333,801 (0%) | 0% | 53.8 | 133,937 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 912 | 336,291 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 8,042 | 8,045 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 13,345 | 194,968 (0%) | 0% | 53.8 | 717,828 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 48,257 | 225,111 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 8,027 | 176,639 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,264 | 175,375 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,353 | 173,022 (0%) | 0% | 53.8 | 126,568 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 8,042 | 181,064 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,386 | 179,678 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,824 | 176,854 (0%) | 0% | 53.8 | 151,903 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 16,798 | 208,313 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| David V. Elkins | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 62,693 | 62,693 | - | - | Performance Shares | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 48,257 | 0 | - | - | Performance Shares | |
| David V. Elkins | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 41,796 | 41,796 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 7,904 | 23,712 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 7,652 | 15,306 | - | - | Market Share Units | |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 8,027 | 0 | - | - | Market Share Units | |
| Giovanni Caforio | Director, Executive Chair of the Board | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 22,214 | 44,429 | - | - | Market Share Units | |
| Giovanni Caforio | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 23,409 | 390,904 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Giovanni Caforio | Director, Executive Chair of the Board | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 3,687 | 387,217 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Giovanni Caforio | Director, Executive Chair of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 10,088 | 377,129 (0%) | 0% | 53.8 | 542,634 | Common Stock, $0.10 par value |
| Giovanni Caforio | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 23,817 | 400,946 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Giovanni Caforio | Director, Executive Chair of the Board | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 4,104 | 396,842 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Giovanni Caforio | Director, Executive Chair of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 10,084 | 386,758 (0%) | 0% | 53.8 | 542,418 | Common Stock, $0.10 par value |
| Giovanni Caforio | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 142,904 | 529,662 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Giovanni Caforio | Director, Executive Chair of the Board | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 49,745 | 479,917 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Giovanni Caforio | Director, Executive Chair of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 47,651 | 432,266 (0%) | 0% | 53.8 | 2,563,147 | Common Stock, $0.10 par value |
| Giovanni Caforio | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 23,409 | 0 | - | - | Market Share Units | |
| Giovanni Caforio | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 23,817 | 23,818 | - | - | Market Share Units | |
| Giovanni Caforio | Director, Executive Chair of the Board | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 23,419 | 70,258 | - | - | Market Share Units | |
| Giovanni Caforio | Director, Executive Chair of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 142,904 | 0 | - | - | Performance Shares | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 5,743 | 0 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 148,026 | 148,026 | - | - | Performance Shares | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,985 | 92,020 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,475 | 85,035 (0%) | 0% | 53.8 | 133,130 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 905 | 87,510 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 5,743 | 88,415 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,204 | 90,816 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,957 | 87,859 (0%) | 0% | 53.8 | 159,057 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 41,910 | 129,769 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 14,589 | 115,180 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 13,975 | 101,205 (0%) | 0% | 53.8 | 751,715 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 41,910 | 0 | - | - | Performance Shares | |
| Christopher S. Boerner | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 98,684 | 98,684 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 6,733 | 20,199 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 6,616 | 13,234 | - | - | Market Share Units | |
| Christopher S. Boerner | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,985 | 6,985 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 23,220 | 23,220 | - | - | Performance Shares | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,985 | 0 | - | - | Performance Shares | |
| Robert M. Plenge | EVP, Chief Research Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 15,480 | 15,480 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 2,342 | 7,026 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,107 | 2,214 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,164 | 1,165 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 994 | 0 | - | - | Market Share Units | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 1,436 | 11,315 (0%) | 0% | 53.8 | 77,242 | Common Stock, $0.10 par value |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 2,431 | 12,751 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 6,985 | 15,182 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 283 | 8,197 (0%) | 0% | 53.8 | 15,223 | Common Stock, $0.10 par value |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 201 | 8,480 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,164 | 8,681 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 246 | 7,517 (0%) | 0% | 53.8 | 13,232 | Common Stock, $0.10 par value |
| Robert M. Plenge | EVP, Chief Research Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 157 | 7,763 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Robert M. Plenge | EVP, Chief Research Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 994 | 7,920 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 4,765 | 9,532 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,885 | 4,886 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,192 | 0 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,192 | 51,437 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 9,774 | 60,279 (0%) | 0% | 53.8 | 525,743 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 10,203 | 70,053 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 29,311 | 80,256 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 2,068 | 50,945 (0%) | 0% | 53.8 | 111,238 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 842 | 53,013 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,885 | 53,855 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 1,807 | 48,970 (0%) | 0% | 53.8 | 97,199 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 660 | 50,777 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 60,952 | 60,952 | - | - | Performance Shares | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 29,311 | 0 | - | - | Performance Shares | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 40,635 | 40,635 | - | - | Market Share Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 5,854 | 17,565 | - | - | Market Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 19,350 | 19,350 | - | - | Market Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 2,836 | 5,675 | - | - | Market Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 29,025 | 29,025 | - | - | Performance Shares | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 3,293 | 9,880 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 3,293 | 9,880 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 2,447 | 4,895 | - | - | Market Share Units | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 34,830 | 34,830 | - | - | Performance Shares | |
| Karin Shanahan | EVP, Glob. Prod. Dev. & Supply | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 23,220 | 23,220 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 31,347 | 31,347 | - | - | Performance Shares | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,698 | 2,224 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 267 | 1,957 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 518 | 1,439 (0%) | 0% | 53.8 | 27,863 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,902 | 3,341 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 328 | 3,013 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 570 | 2,443 (0%) | 0% | 53.8 | 30,660 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 11,416 | 13,859 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 3,974 | 9,885 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 3,235 | 6,650 (0%) | 0% | 53.8 | 174,011 | Common Stock, $0.10 par value |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,698 | 0 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 1,902 | 1,904 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,825 | 3,653 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 2,000 | 6,001 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 20,898 | 20,898 | - | - | Market Share Units | |
| Adam Lenkowsky | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 11,416 | 0 | - | - | Performance Shares | |
| Cari Gallman | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 11,029 | 11,029 | - | - | Performance Shares | |
| Cari Gallman | EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 7,353 | 7,353 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 867 | 2,601 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 910 | 1,822 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 349 | 349 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 318 | 0 | - | - | Market Share Units | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 494 | 1,432 (0%) | 0% | 53.8 | 26,572 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 2,094 | 0 | - | - | Performance Shares | |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 729 | 1,926 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 2,094 | 2,655 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 105 | 561 (0%) | 0% | 53.8 | 5,648 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 60 | 666 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 349 | 726 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 97 | 377 (0%) | 0% | 53.8 | 5,218 | Common Stock, $0.10 par value |
| Cari Gallman | EVP, Corporate Affairs | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 50 | 474 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Cari Gallman | EVP, Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 318 | 524 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 194 | 513 (0%) | 0% | 53.8 | 10,435 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 544 | 801 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 197 | 257 (0%) | 0% | 53.8 | 10,597 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 85 | 454 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 539 | 0 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 539 | 539 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 917 | 1,726 (0%) | 0% | 53.8 | 49,325 | Common Stock, $0.10 par value |
| Lynelle Hoch | President, Cell Therapy Org. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 7,546 | 7,546 | - | - | Performance Shares | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,268 | 0 | - | - | Performance Shares | |
| Lynelle Hoch | President, Cell Therapy Org. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 5,031 | 5,031 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,050 | 3,152 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 835 | 1,673 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 544 | 546 | - | - | Market Share Units | |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,138 | 2,643 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 3,268 | 3,781 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Lynelle Hoch | President, Cell Therapy Org. | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 94 | 707 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 803 | 2,411 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 628 | 628 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 99 | 529 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 192 | 337 (0%) | 0% | 53.8 | 10,328 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 690 | 1,027 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 119 | 908 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 207 | 701 (0%) | 0% | 53.8 | 11,135 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,140 | 4,841 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,441 | 3,400 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 976 | 2,424 (0%) | 0% | 53.8 | 52,499 | Common Stock, $0.10 par value |
| Amanda Ahn Poole | EVP, Chief Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 628 | 0 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 690 | 690 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 810 | 1,621 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 11,397 | 11,397 | - | - | Market Share Units | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,140 | 0 | - | - | Performance Shares | |
| Amanda Ahn Poole | EVP, Chief Human Resources | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 17,096 | 17,096 | - | - | Performance Shares | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 701 | 701 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 810 | 1,621 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 768 | 2,307 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 4,938 | 4,938 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,206 | 0 | - | - | Performance Shares | |
| Phil Holzer | SVP and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2024 | 7,407 | 7,407 | - | - | Performance Shares | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 613 | 0 | - | - | Market Share Units | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 992 | 12,460 (0%) | 0% | 53.8 | 53,360 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 1,464 | 13,452 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 4,206 | 14,916 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 210 | 10,710 (0%) | 0% | 53.8 | 11,296 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 121 | 10,920 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 701 | 11,041 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.79 per share. | 10 Mar 2024 | 187 | 10,340 (0%) | 0% | 53.8 | 10,059 | Common Stock, $0.10 par value |
| Phil Holzer | SVP and Controller | Other type of transaction at price $ 0.00 per share. | 10 Mar 2024 | 97 | 10,527 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Phil Holzer | SVP and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2024 | 613 | 10,624 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| L. Gerald Storch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 87,467 | - | - | Deferred Share Units | |
| L. Bhatt Deepak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 9,889 | - | - | Deferred Share Units | |
| Medina Manuel Hidalgo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 13,616 | - | - | Deferred Share Units | |
| Arduini J. Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 52,063 | - | - | Deferred Share Units | |
| Phyllis R. Yale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 26,949 | - | - | Deferred Share Units | |
| Scott Gregory Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 2,543 | 5,086 | - | - | Restricted Stock Units | |
| Derica Rice W. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 22,942 | - | - | Deferred Share Units | |
| Gregory Scott Meyers | EVP, Chief Digital & Tech Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 2,543 | 6,040 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| H. Karen Vousden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 30,211 | - | - | Deferred Share Units | |
| Theodore Samuels R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 46,936 | - | - | Deferred Share Units | |
| Price Paula A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 16,094 | - | - | Deferred Share Units | |
| Gregory Meyers Scott | EVP, Chief Digital & Tech Off. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.67 per share. | 01 Feb 2024 | 754 | 5,286 (0%) | 0% | 48.7 | 36,697 | Common Stock, $0.10 par value |
| Julia Haller A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 27,341 | - | - | Deferred Share Units | |
| Yale Phyllis R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 657 | 22,359 | - | - | Deferred Share Units | |
| Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 950 | 42,103 | - | - | Deferred Share Units | |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 706 | 18,401 | - | - | Deferred Share Units | |
| J. Arduini Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 657 | 47,167 | - | - | Deferred Share Units | |
| Storch Gerald L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 706 | 82,139 | - | - | Deferred Share Units | |
| A. Haller Julia | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 706 | 22,746 | - | - | Deferred Share Units | |
| Hidalgo Medina Manuel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 164 | 9,188 | - | - | Deferred Share Units | |
| Deepak Bhatt L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 164 | 5,506 | - | - | Deferred Share Units | |
| Boerner Christopher S. | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 49.78 per share. | 05 Dec 2023 | 2,000 | 82,672 (0%) | 0% | 49.8 | 99,560 | Common Stock, $0.10 par value |
| V. Elkins David | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 8,792 | 0 | - | - | Restricted Stock Units | |
| Boerner S. Christopher | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.10 per share. | 02 Dec 2023 | 1,350 | 80,672 (0%) | 0% | 50.1 | 67,635 | Common Stock, $0.10 par value |
| Boerner S. Christopher | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 2,638 | 0 | - | - | Restricted Stock Units | |
| David V. Elkins | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.10 per share. | 02 Dec 2023 | 3,730 | 168,612 (0%) | 0% | 50.1 | 186,873 | Common Stock, $0.10 par value |
| David V. Elkins | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 8,792 | 172,342 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher Boerner S. | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2023 | 2,638 | 82,022 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Christopher S. Boerner | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 48.86 per share. | 28 Nov 2023 | 3,071 | 79,384 (0%) | 0% | 48.9 | 150,049 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 48.74 per share. | 21 Nov 2023 | 9,830 | 331,414 (0%) | 0% | 48.7 | 479,163 | Common Stock, $0.10 par value |
| Sandra Leung | EVP, General Counsel | Other type of transaction at price $ 48.74 per share. | 21 Nov 2023 | 9,830 | 93,436 (0%) | 0% | 48.7 | 479,163 | Common Stock, $0.10 par value |
| Theodore R. Samuels | Director | Purchase of securities on an exchange or from another person at price $ 49.81 per share. | 20 Nov 2023 | 8,500 | 35,500 (0%) | 0% | 49.8 | 423,385 | Common Stock, $0.10 par value |
| Christopher S. Boerner | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2023 | 17,788 | 17,788 | - | - | Performance Shares | |
| Christopher S. Boerner | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2023 | 11,858 | 11,858 | - | - | Market Share Units | |
| Giovanni Caforio | Director, Board Chair and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Oct 2023 | 440 | 367,495 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Derica W. Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 624 | 17,499 | - | - | Deferred Share Units | |
| Gerald L. Storch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 624 | 80,538 | - | - | Deferred Share Units | |
| Phyllis R. Yale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 581 | 21,463 | - | - | Deferred Share Units | |
| Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 581 | 45,997 | - | - | Deferred Share Units | |
| Julia A. Haller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 624 | 21,797 | - | - | Deferred Share Units | |
| Theodore R. Samuels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 839 | 40,700 | - | - | Deferred Share Units | |
| Deepak L. Bhatt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 145 | 5,283 | - | - | Deferred Share Units | |
| Powell Ann Judge | EVP, Chief Human Resources | Sale of securities on an exchange or to another person at price $ 61.25 per share. | 24 Aug 2023 | 17,986 | 27,868 (0%) | 0% | 61.3 | 1,101,643 | Common Stock, $0.10 par value |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 9,357 | 0 | - | - | Restricted Stock Units | |
| Samit Hirawat | EVP,Chief Med.Offr.,Drug Dev. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 9,357 | 52,032 (0%) | 0% | 0 | Common Stock, $0.10 par value |